Literature DB >> 26033159

Recurrent DICER1 hotspot mutations in endometrial tumours and their impact on microRNA biogenesis.

Jiamin Chen1,2, Yemin Wang1,2, Melissa K McMonechy1,2, Michael S Anglesio1, Winnie Yang2, Janine Senz1, Sarah Maines-Bandiera1, Jamie Rosner3, Genny Trigo-Gonzalez4, S W Grace Cheng4, Jaeyeon Kim5, Martin M Matzuk5, Gregg B Morin6,4, David G Huntsman1,7,2.   

Abstract

DICER1 plays a critical role in microRNA (miRNA) biogenesis. Recurrent somatic 'hotspot' mutations at the four metal-binding sites within the RNase IIIb domain of DICER1 were identified in ovarian sex cord-stromal tumours and have since been described in other paediatric tumours. In this study, we screened the RNase IIIb domain of DICER1 in 290 endometrial tumours and identified six cases with hotspot mutations, including two cases affected by an atypical G1809R mutation directly adjacent to a metal-binding site. Using Illumina and Sanger targeted resequencing, we observed and validated biallelic DICER1 mutations in several cases with hotspot mutations. Through in vitro DICER1 cleavage assays, small RNA deep sequencing and real-time PCR, we demonstrated that mutations adding a positively charged side chain to residue 1809 have similar detrimental effects on 5p miRNA production to mutations at the metal-binding sites. As expected, 5p miRNAs were globally reduced in tumours and cell lines with hotspot mutations. Pathway analysis of gene expression profiles indicated that genes de-repressed due to loss of 5p miRNAs are strongly associated with pathways regulating the cell cycle. Using a Dicer1-null mouse cell line model, we found that expression of DICER1 hotspot mutants promoted cell proliferation, whereas wild-type (WT) DICER1 inhibited cell proliferation. Furthermore, targets of let-7 family miRNAs are enriched among the up-regulated genes, suggesting that loss of let-7 may be impacting downstream pathways. Our results reveal that DICER1 hotspot mutations are implicated in common malignancies and may constitute a unique oncogenic pathway.
Copyright © 2015 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  DICER1; cell cycle; hotspot mutations; let-7; miRNA

Mesh:

Substances:

Year:  2015        PMID: 26033159     DOI: 10.1002/path.4569

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  19 in total

1.  Expanding the spectrum of dicer1-associated sarcomas.

Authors:  Mikako Warren; Matthew C Hiemenz; Ryan Schmidt; Jared Shows; Jennifer Cotter; Stephanie Toll; David M Parham; Jaclyn A Biegel; Leo Mascarenhas; Rachana Shah
Journal:  Mod Pathol       Date:  2019-09-19       Impact factor: 7.842

2.  DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry.

Authors:  Kris Ann P Schultz; Anne K Harris; Michael Finch; Louis P Dehner; Jubilee B Brown; David M Gershenson; Robert H Young; Amanda Field; Weiying Yu; Joyce Turner; Nicholas G Cost; Dominik T Schneider; Douglas R Stewart; A Lindsay Frazier; Yoav Messinger; D Ashley Hill
Journal:  Gynecol Oncol       Date:  2017-10-14       Impact factor: 5.482

3.  Role of Dicer1 in thyroid cell proliferation and differentiation.

Authors:  Ricardo Cortez Cardoso Penha; Romina Sepe; Marco De Martino; Francesco Esposito; Simona Pellecchia; Maddalena Raia; Luigi Del Vecchio; Myriam Decaussin-Petrucci; Gabriella De Vita; Luis Felipe Ribeiro Pinto; Alfredo Fusco
Journal:  Cell Cycle       Date:  2017-11-09       Impact factor: 4.534

4.  DICER1 mutations in primary central nervous system tumors: new insights into histologies, mutations, and prognosis.

Authors:  Kevin X Liu; Helen H Shang; Chantel Cacciotti; Emily Everdell; Ayal A Aizer; Rifaquat Rahman; Seth Malinowski; David M Meredith; Junne Kamihara; Patrick Y Wen; Keith L Ligon; Susan N Chi; Karen J Marcus; Kee Kiat Yeo; Sanda Alexandrescu; Daphne A Haas-Kogan
Journal:  J Neurooncol       Date:  2022-04-06       Impact factor: 4.130

Review 5.  The role of MicroRNA molecules and MicroRNA-regulating machinery in the pathogenesis and progression of epithelial ovarian cancer.

Authors:  Xiyin Wang; Mircea Ivan; Shannon M Hawkins
Journal:  Gynecol Oncol       Date:  2017-08-31       Impact factor: 5.482

6.  Significantly greater prevalence of DICER1 alterations in uterine embryonal rhabdomyosarcoma compared to adenosarcoma.

Authors:  Leanne de Kock; Ju-Yoon Yoon; Blaise A Clarke; William D Foulkes; Maria Apellaniz-Ruiz; Dylan Pelletier; W Glenn McCluggage; Colin J R Stewart; Brendan C Dickson; Marjan Rouzbahman
Journal:  Mod Pathol       Date:  2020-01-03       Impact factor: 7.842

7.  Pten and Dicer1 loss in the mouse uterus causes poorly differentiated endometrial adenocarcinoma.

Authors:  Xiyin Wang; Jillian R H Wendel; Robert E Emerson; Russell R Broaddus; Chad J Creighton; Douglas B Rusch; Aaron Buechlein; Francesco J DeMayo; John P Lydon; Shannon M Hawkins
Journal:  Oncogene       Date:  2020-08-25       Impact factor: 9.867

8.  Molecular characterization of DICER1-mutated pituitary blastoma.

Authors:  Javad Nadaf; Leanne de Kock; Anne-Sophie Chong; Márta Korbonits; Paul Thorner; Naciba Benlimame; Lili Fu; Andrew Peet; Justin Warner; Oswald Ploner; Shanop Shuangshoti; Steffen Albrecht; Nancy Hamel; John R Priest; Barbara Rivera; Jiannis Ragoussis; William D Foulkes
Journal:  Acta Neuropathol       Date:  2021-03-01       Impact factor: 17.088

9.  Clinicopathologic and molecular analysis of embryonal rhabdomyosarcoma of the genitourinary tract: evidence for a distinct DICER1-associated subgroup.

Authors:  Andreas von Deimling; Christian Koelsche; Felix K F Kommoss; Damian Stichel; Jaume Mora; Manel Esteller; David T W Jones; Stefan M Pfister; Eva Brack; Marco Wachtel; Peter Karl Bode; Hans-Peter Sinn; Dietmar Schmidt; Thomas Mentzel; Friedrich Kommoss; Felix Sahm
Journal:  Mod Pathol       Date:  2021-04-12       Impact factor: 7.842

10.  Sequencing of DICER1 in sarcomas identifies biallelic somatic DICER1 mutations in an adult-onset embryonal rhabdomyosarcoma.

Authors:  Leanne de Kock; Barbara Rivera; Timothée Revil; Paul Thorner; Catherine Goudie; Dorothée Bouron-Dal Soglio; Catherine S Choong; John R Priest; Paul J van Diest; Jantima Tanboon; Anja Wagner; Jiannis Ragoussis; Peter Fm Choong; William D Foulkes
Journal:  Br J Cancer       Date:  2017-05-18       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.